Climb Bio (CLYM) Free Cash Flow (2020 - 2026)
Climb Bio (CLYM) posted Free Cash Flow of -$14.4 million for Q1 2026, up 8.03% on a QoQ basis from -$15.6 million in Q4 2025, and up 6.9% year-over-year from -$13.5 million in Q1 2025.
Climb Bio (CLYM) Free Cash Flow (2020 - 2026) Analysis & Trends
Climb Bio's Free Cash Flow history runs 7 years deep, the most recent figure standing at -$14.4 million for Q1 2026.
- Quarterly Free Cash Flow rose 6.9% year-over-year to -$14.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$54.8 million (down 86.49% YoY) and the FY2025 annual result came in at -$55.9 million, down 254.46% from the prior year.
- Free Cash Flow was -$14.4 million for Q1 2026 at Climb Bio, up from -$15.6 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $3.5 million in Q3 2023 and bottomed at -$15.6 million in Q4 2025.
- A 5-year average of -$8.5 million and a median of -$8.4 million in 2022 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2023 — Free Cash Flow jumped 183.59% — and 2025, when it plunged 1581.26%.
- Climb Bio's Free Cash Flow stood at -$8.4 million in 2022, then soared by 88.79% to -$947000.0 in 2023, then plunged by 505.7% to -$5.7 million in 2024, then tumbled by 172.58% to -$15.6 million in 2025, then gained by 8.03% to -$14.4 million in 2026.
- Business Quant data shows CLYM's Free Cash Flow at -$14.4 million in Q1 2026, -$15.6 million in Q4 2025, and -$13.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Climb Bio | 870.33 Mn | 870.33 Mn | - | -14.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.38 Mn |
| Mar 31, 2026 | -14.38 Mn |
| Dec 31, 2025 | -15.64 Mn |
| Dec 31, 2025 | -15.64 Mn |
| Sep 30, 2025 | -13.58 Mn |
| Sep 30, 2025 | -13.58 Mn |
| Jun 30, 2025 | -11.21 Mn |
| Jun 30, 2025 | -11.21 Mn |
| Mar 31, 2025 | -15.44 Mn |
| Mar 31, 2025 | -15.44 Mn |
| Dec 31, 2024 | -5.74 Mn |
| Dec 31, 2024 | -5.74 Mn |
| Sep 30, 2024 | -7.54 Mn |
| Sep 30, 2024 | -7.54 Mn |
| Jun 30, 2024 | -667,000.00 |
| Jun 30, 2024 | -667,000.00 |
| Mar 31, 2024 | -1.82 Mn |
| Mar 31, 2024 | -1.82 Mn |
| Dec 31, 2023 | -947,000.00 |
| Dec 31, 2023 | -947,000.00 |